Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Summary

The CC-90003-ST -001 trial is a first-in-man, open-label study in subjects with locally-advanced or wide spread cancers to determine if CC-90003 (an oral medication) can be adequately tolerated with minimal side effects.

Timeline

Start

2015-01-05

Primary completion

2016-05-03

Completion

2016-05-03

Drugs

Indications